BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21969083)

  • 1. Improving nodal harvest in colorectal cancer: so what?
    Porter GA; Urquhart R; Bu J; Johnson P; Rayson D; Grunfeld E
    Ann Surg Oncol; 2012 Apr; 19(4):1066-73. PubMed ID: 21969083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of audit and feedback on nodal harvest in colorectal cancer.
    Porter GA; Urquhart R; Bu J; Johnson P; Grunfeld E
    BMC Cancer; 2011 Jan; 11():2. PubMed ID: 21199578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
    Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
    Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining stage IIB survival in a population-based cohort of patients with colorectal cancer.
    Urquhart R; Bu J; Grunfeld E; Dewar R; MacIntyre M; Porter GA
    Cancer; 2012 Dec; 118(23):5973-81. PubMed ID: 22648789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
    Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
    Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node evaluation in colorectal cancer patients: a population-based study.
    Baxter NN; Virnig DJ; Rothenberger DA; Morris AM; Jessurun J; Virnig BA
    J Natl Cancer Inst; 2005 Feb; 97(3):219-25. PubMed ID: 15687365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the quality of colorectal cancer staging: documenting the process in improving the staging of node-negative colorectal cancer.
    Wong JH; Johnson DS; Hemmings D; Hsu A; Imai T; Tominaga GT
    Arch Surg; 2005 Sep; 140(9):881-6; discussion 886-7. PubMed ID: 16172297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of nodal involvement in T2 colorectal cancer.
    Kajiwara Y; Ueno H; Hashiguchi Y; Mochizuki H; Hase K
    Dis Colon Rectum; 2010 Oct; 53(10):1393-9. PubMed ID: 20847621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer.
    Welter S; Jacobs J; Krbek T; Poettgen C; Stamatis G
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):167-72. PubMed ID: 17150367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
    Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
    Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal number of lymph nodes that need to be examined for adequate staging of colorectal cancer--factors influencing lymph node harvest.
    Horzic M; Kopljar M
    Hepatogastroenterology; 2005; 52(61):86-9. PubMed ID: 15783001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number of analyzed lymph nodes - a prognostic factor in colorectal cancer.
    Edler D; Ohrling K; Hallström M; Karlberg M; Ragnhammar P
    Acta Oncol; 2007; 46(7):975-81. PubMed ID: 17917828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of propensity score model to examine the prognostic significance of lymph node number as a care quality indicator.
    Chang YJ; Chen LJ; Chang YJ; Chung KP; Lai MS
    Surg Oncol; 2012 Jun; 21(2):e75-85. PubMed ID: 22221938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital-to-hospital variation in lymph node detection after colorectal resection.
    Miller EA; Woosley J; Martin CF; Sandler RS
    Cancer; 2004 Sep; 101(5):1065-71. PubMed ID: 15329917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting.
    Chapuis PH; Bokey EL; Clarke S; Beale P; Dent OF
    ANZ J Surg; 2009 Oct; 79(10):685-92. PubMed ID: 19878161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic lymph node size and colorectal cancer prognosis.
    Dhar DK; Yoshimura H; Kinukawa N; Maruyama R; Tachibana M; Kohno H; Kubota H; Nagasue N
    J Am Coll Surg; 2005 Jan; 200(1):20-8. PubMed ID: 15631916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the ratio of positive to total lymph nodes examined and outcome in colorectal cancer.
    Ng M; Roy-Chowdhury S; Lum SS; Morgan JW; Wong JH
    Am Surg; 2009 Oct; 75(10):873-6. PubMed ID: 19886125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.